These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S. Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733 [Abstract] [Full Text] [Related]
8. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Esteghamati A, Noshad S, Khalilzadeh O, Khalili M, Zandieh A, Nakhjavani M. Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060 [Abstract] [Full Text] [Related]
9. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH. Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131 [Abstract] [Full Text] [Related]
10. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. Sogabe M, Okahisa T, Kurihara T, Takehara M, Kagemoto K, Okazaki J, Kida Y, Hirao A, Tanaka H, Tomonari T, Taniguchi T, Okamoto K, Nakasono M, Takayama T. PLoS One; 2020 Dec; 15(8):e0238388. PubMed ID: 32866186 [Abstract] [Full Text] [Related]
11. Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010. Lee K, Yang JH. Metab Syndr Relat Disord; 2013 Aug; 11(4):229-35. PubMed ID: 23451816 [Abstract] [Full Text] [Related]
13. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Askari F, Rashidkhani B, Hekmatdoost A. Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315 [Abstract] [Full Text] [Related]
14. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, Kim HC. Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075 [Abstract] [Full Text] [Related]
15. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. Verrijken A, Francque S, Mertens I, Talloen M, Peiffer F, Van Gaal L. Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825 [Abstract] [Full Text] [Related]
16. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding. Folini L, Veronelli A, Benetti A, Pozzato C, Cappelletti M, Masci E, Micheletto G, Pontiroli AE. Acta Diabetol; 2014 May; 51(3):361-8. PubMed ID: 24085682 [Abstract] [Full Text] [Related]
17. Body mass index and waist circumference in non-alcoholic fatty liver disease. Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA. J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132 [Abstract] [Full Text] [Related]
18. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ. J Zhejiang Univ Sci B; 2008 Aug; 9(8):616-22. PubMed ID: 18763311 [Abstract] [Full Text] [Related]
19. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin. Gonciarz M, Gonciarz Z, Bielanski W, Mularczyk A, Konturek PC, Brzozowski T, Konturek SJ. J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501 [Abstract] [Full Text] [Related]